1. Home
  2. BJDX vs VTAK Comparison

BJDX vs VTAK Comparison

Compare BJDX & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$1.90

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.36

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BJDX
VTAK
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.9M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BJDX
VTAK
Price
$1.90
$1.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
107.6K
784.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
86.65
89.53
EPS
N/A
N/A
Revenue
$249,040.00
$442,000.00
Revenue This Year
N/A
$822.86
Revenue Next Year
$55.56
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3057.14
52 Week Low
$0.63
$0.15
52 Week High
$10.20
$4.31

Technical Indicators

Market Signals
Indicator
BJDX
VTAK
Relative Strength Index (RSI) 45.09 40.50
Support Level $1.47 $1.14
Resistance Level $2.47 $2.05
Average True Range (ATR) 0.15 0.13
MACD -0.04 0.00
Stochastic Oscillator 50.00 6.71

Price Performance

Historical Comparison
BJDX
VTAK

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: